adMare BioInnovations (BLU-5937 and P2X3 Intellectual Property Assets) is Buildings and Property in Canada that focus on Intellectual property assets business. They cover business area such as intellectual property asset, a key sensory receptor, irritation, pain, either condition.
-
Intellectual Property Assets
-
2405 Wesbrook Mall
4th Floor
Vancouver, British Columbia V6T 1Z3
Canada
Private
intellectual property asseta key sensory receptorirritationpaineither condition
* We use standard office opening hours in near adMare BioInnovations (BLU-5937 and P2X3 Intellectual Property Assets)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
AdMare BioInnovations (BLU-5937 And P2X3 Intellectual Property Assets) is Buildings and Property business from Canada that founded in - ( years old in ), adMare BioInnovations (BLU-5937 and P2X3 Intellectual Property Assets) business is focusing on Intellectual Property Assets.
adMare BioInnovations (BLU-5937 and P2X3 Intellectual Property Assets) headquarter office and corporate office address is located in 2405 Wesbrook Mall 4th Floor Vancouver, British Columbia V6T 1Z3 Canada.
adMare BioInnovations (BLU-5937 and P2X3 Intellectual Property Assets) was founded in Canada.
In , adMare BioInnovations (BLU-5937 and P2X3 Intellectual Property Assets) is currently focus on Intellectual property assets sector.
Above is snippet of Google Trends for "Intellectual property assets" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with adMare BioInnovations (BLU-5937 and P2X3 Intellectual Property Assets), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
